Rajan P. Kulkarni is currently working as an Associate Professor of Dermatology, at Oregon Health and Science University, Portland, OR, USA. His research focuses on the intersection of basic biology, technology, and medicine to help better achieve the vision of personalized medicine in cancer. His research is focused on basic and translational studies to enable molecular-based, personalized approaches to cancer care, in collaboration with the VA, the Center for Early Detection Research (CEDAR), and the Knight Cancer Institute (KCI). A parallel line of research focuses on oncodermatology and elucidating the mechanisms by which novel chemotherapeutics and immunotherapies cause skin toxicities/rashes and whether these mechanisms have any correlation with anti-tumor effects and overall outcomes. The overall goal is to couple genomic, epigenetic, and clinical information to design novel treatment strategies and ultimately improve patient outcomes.